title: Effect of interferon and 5-fluorouracil on serum VEGF levels in neuroendocrine tumours.
authors.forename: Anouk N A
authors.initials: AN
authors.lastname: Van Der Horst-Schrivers
authors.forename: Madeleine H E Bruins
authors.initials: MH
authors.lastname: Slot
authors.forename: Pax H B
authors.initials: PH
authors.lastname: Willemse
authors.forename: Ido P
authors.initials: IP
authors.lastname: Kema
authors.forename: Elisabeth G E
authors.initials: EG
authors.lastname: De Vries
authors.forename: A N Machteld
authors.initials: AN
authors.lastname: Wymenga
mesh_terms: D020533:Angiogenesis Inhibitors / Q000008:administration & dosage; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000009:adverse effects / Q000627:therapeutic use*; D017209:Apoptosis; D005472:Fluorouracil / Q000008:administration & dosage / Q000009:adverse effects; D006801:Humans; D007155:Immunologic Factors / Q000008:administration & dosage; D016898:Interferon-alpha / Q000008:administration & dosage / Q000009:adverse effects; D018358:Neuroendocrine Tumors / Q000097:blood / Q000188:drug therapy* / Q000556:secondary*; D017211:Treatment Failure; D042461:Vascular Endothelial Growth Factor A / Q000097:blood / Q000187:drug effects*
chemical_list: D020533:Angiogenesis Inhibitors; D007155:Immunologic Factors; D016898:Interferon-alpha; D042461:Vascular Endothelial Growth Factor A; D005472:Fluorouracil